Search for a command to run...
No recent news available for this stock.
Conference call summary is not available for this stock.
Anuh Pharma Ltd. is currently lagging behind its peers in key financial metrics. While it shows no significant debt, its lack of growth and profitability metrics indicates a need for improvement. In contrast, companies like Sun Pharmaceuticals and Dr. Reddy's Laboratories exhibit strong growth and profitability, making them sector leaders. Anuh Pharma's current valuation appears attractive, but without evident growth, it may not be a compelling investment at this time.
Strong revenue growth (YoY: 8.42%) and high profitability metrics with a ROE of 16.13%.
Solid growth trajectory with 16.54% revenue growth YoY and a strong ROE of 21.76%.
Promising revenue growth of 13.28% YoY and a decent ROE of 16.63%.